• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族性致死病史和遗传方式在根治性前列腺切除术后前列腺癌长期预后中的作用。

The role of fatal family history and mode of inheritance in prostate cancer for long-term outcomes following radical prostatectomy.

机构信息

Technical University of Munich, School of Medicine, Klinikum rechts der Isar, Department of Urology, Munich, Germany.

Institute of Epidemiology and Medical Biometrics, University of Ulm, Ulm, Germany.

出版信息

World J Urol. 2020 Dec;38(12):3091-3099. doi: 10.1007/s00345-020-03147-6. Epub 2020 Mar 11.

DOI:10.1007/s00345-020-03147-6
PMID:32161996
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7716855/
Abstract

PURPOSE

To determine whether fatal family history (FFH) or mode of inheritance in prostate cancer (PCa) has an impact on long-term outcomes following radical prostatectomy (RP).

METHODS

1076 PCa patients after RP with at least one deceased first-degree relative with PCa were included and stratified by FFH (four subgroups: fraternal, paternal, multiple, and none) and by mode of inheritance (two subgroups: male to male, non-male to male). We compared clinicopathological characteristics between subgroups with Fisher's exact or Chi-square tests. Biochemical recurrence-free survival (BRFS) and cancer-specific survival (CSS) were analyzed using the method of Kaplan and Meier. Simple and multiple Cox regression with backward elimination were performed to select prognostic factors for BRFS and CSS.

RESULTS

Median age at surgery was 63.3 (range 35.9-79.4) years. The overall Kaplan-Meier estimated BRFS rate at 10 and 15 years was 65.6% and 57.0%, respectively. The overall Kaplan-Meier estimated CSS rate at 10 and 15 years was 98.1% and 95.7%, respectively. Neither FFH nor mode of inheritance were factors associated with worse BRFS. However, in multiple Cox regression, paternal FFH was an important prognostic factor for a better CSS (HR 0.19, CI 0.05-0.71, p = 0.014) compared to non-FFH.

CONCLUSION

FFH and mode of inheritance do not seem to be prognostic factors of worse long-term outcomes following RP. Rather, a paternal FFH was associated with a better CSS; however, the reasons remain unclear. Nevertheless, patients after RP and FFH could be reassured that their own PCa diagnosis is not associated with a worse long-term outcome.

摘要

目的

确定前列腺癌(PCa)患者的家族性致死病史(FFH)或遗传模式是否会对根治性前列腺切除术(RP)后的长期预后产生影响。

方法

共纳入 1076 例 RP 术后且至少有一位一级亲属死于 PCa 的 PCa 患者,并根据 FFH(四亚组:兄弟、父亲、多个、无)和遗传模式(两亚组:男传男、非男传男)进行分层。我们使用 Fisher 精确检验或卡方检验比较亚组间的临床病理特征。采用 Kaplan-Meier 法分析生化无复发生存率(BRFS)和癌症特异性生存率(CSS)。采用简单和多元 Cox 回归分析,使用逐步后退法筛选 BRFS 和 CSS 的预后因素。

结果

中位手术年龄为 63.3 岁(范围 35.9-79.4)。10 年和 15 年的总体 Kaplan-Meier 估计 BRFS 率分别为 65.6%和 57.0%。10 年和 15 年的总体 Kaplan-Meier 估计 CSS 率分别为 98.1%和 95.7%。FFH 或遗传模式均不是 BRFS 预后不良的因素。然而,在多元 Cox 回归中,与无 FFH 相比,父亲 FFH 是 CSS 更好的重要预后因素(HR 0.19,CI 0.05-0.71,p=0.014)。

结论

FFH 和遗传模式似乎不是 RP 后长期预后不良的预后因素。相反,父亲 FFH 与 CSS 更好相关;然而,原因尚不清楚。尽管如此,RP 术后且有 FFH 的患者可以放心,他们自己的 PCa 诊断与长期预后不良无关。

相似文献

1
The role of fatal family history and mode of inheritance in prostate cancer for long-term outcomes following radical prostatectomy.家族性致死病史和遗传方式在根治性前列腺切除术后前列腺癌长期预后中的作用。
World J Urol. 2020 Dec;38(12):3091-3099. doi: 10.1007/s00345-020-03147-6. Epub 2020 Mar 11.
2
Men with family history of prostate cancer have a higher risk of disease recurrence after radical prostatectomy.有前列腺癌家族史的男性在根治性前列腺切除术后疾病复发的风险更高。
World J Urol. 2018 Feb;36(2):177-185. doi: 10.1007/s00345-017-2122-5. Epub 2017 Nov 21.
3
Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.根治性前列腺切除术是治疗标本中存在高病理 Gleason 评分前列腺癌的有效方法。
BJU Int. 2013 May;111(5):723-30. doi: 10.1111/j.1464-410X.2012.11114.x. Epub 2012 Apr 4.
4
Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.根治性前列腺切除术改善了 PSA 时代淋巴结阳性前列腺癌男性的无进展生存期和癌症特异性生存期:一项确认性研究。
BJU Int. 2011 Jun;107(11):1755-61. doi: 10.1111/j.1464-410X.2010.09730.x. Epub 2010 Oct 13.
5
Perioperative Blood Transfusion as a Significant Predictor of Biochemical Recurrence and Survival after Radical Prostatectomy in Patients with Prostate Cancer.围手术期输血是前列腺癌患者根治性前列腺切除术后生化复发和生存的重要预测因素。
PLoS One. 2016 May 9;11(5):e0154918. doi: 10.1371/journal.pone.0154918. eCollection 2016.
6
Long-term radical prostatectomy outcomes among participants from the European Randomized Study of Screening for Prostate Cancer (ERSPC) Rotterdam.欧洲前列腺癌筛查随机研究(ERSPC)鹿特丹参与者的长期根治性前列腺切除术结果。
BJU Int. 2012 Dec;110(11):1678-83. doi: 10.1111/j.1464-410X.2012.11367.x. Epub 2012 Sep 21.
7
Natural History of Clinical Recurrence Patterns of Lymph Node-Positive Prostate Cancer After Radical Prostatectomy.淋巴结阳性前列腺癌根治术后临床复发模式的自然史。
Eur Urol. 2016 Jan;69(1):135-42. doi: 10.1016/j.eururo.2015.03.036. Epub 2015 Apr 10.
8
Intermediate-term cancer control outcomes in prostate cancer patients treated with robotic-assisted laparoscopic radical prostatectomy: a multi-institutional analysis.接受机器人辅助腹腔镜根治性前列腺切除术的前列腺癌患者的中期癌症控制结果:一项多机构分析。
World J Urol. 2016 Oct;34(10):1357-66. doi: 10.1007/s00345-016-1781-y. Epub 2016 Feb 12.
9
Persistent Prostate-Specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes.根治性前列腺切除术后前列腺特异性抗原持续存在及其对肿瘤学结局的影响。
Eur Urol. 2019 Jul;76(1):106-114. doi: 10.1016/j.eururo.2019.01.048. Epub 2019 Feb 14.
10
Long-term and pathological outcomes of low- and intermediate-risk prostate cancer after radical prostatectomy: implications for active surveillance.根治性前列腺切除术后低危和中危前列腺癌的长期和病理结局:对主动监测的影响。
World J Urol. 2021 Oct;39(10):3763-3770. doi: 10.1007/s00345-021-03717-2. Epub 2021 May 10.

引用本文的文献

1
Prevalence and determinants of decision regret in long-term prostate cancer survivors following radical prostatectomy.根治性前列腺切除术治疗后长期前列腺癌幸存者决策后悔的发生率及决定因素。
BMC Urol. 2023 Aug 23;23(1):139. doi: 10.1186/s12894-023-01311-9.
2
Long-term and pathological outcomes of low- and intermediate-risk prostate cancer after radical prostatectomy: implications for active surveillance.根治性前列腺切除术后低危和中危前列腺癌的长期和病理结局:对主动监测的影响。
World J Urol. 2021 Oct;39(10):3763-3770. doi: 10.1007/s00345-021-03717-2. Epub 2021 May 10.
3
No detrimental effect of a positive family history on postoperative upgrading and upstaging in men with low risk and favourable intermediate-risk prostate cancer: implications for active surveillance.

本文引用的文献

1
Is time from diagnosis to radical prostatectomy associated with oncological outcomes?从诊断到根治性前列腺切除术的时间是否与肿瘤学结果相关?
World J Urol. 2019 Aug;37(8):1571-1580. doi: 10.1007/s00345-018-2570-6. Epub 2018 Nov 27.
2
Time between diagnosis and surgical treatment on pathological and clinical outcomes in prostate cancer: does it matter?前列腺癌诊断与手术治疗之间的时间间隔对病理和临床结局的影响:这有关系吗?
World J Urol. 2018 Aug;36(8):1225-1231. doi: 10.1007/s00345-018-2251-5. Epub 2018 Mar 16.
3
Association between race and oncologic outcome following radical prostatectomy for clinically organ-confined prostate cancer: a long-term follow-up study.
在低危和有利的中危前列腺癌男性中,阳性家族史对术后升级和分期的不利影响:对主动监测的影响。
World J Urol. 2021 Jul;39(7):2499-2506. doi: 10.1007/s00345-020-03485-5. Epub 2020 Oct 13.
种族与临床局限性前列腺癌根治性前列腺切除术后肿瘤学结果的关系:一项长期随访研究。
World J Urol. 2018 Aug;36(8):1233-1239. doi: 10.1007/s00345-018-2266-y. Epub 2018 Mar 13.
4
Men with family history of prostate cancer have a higher risk of disease recurrence after radical prostatectomy.有前列腺癌家族史的男性在根治性前列腺切除术后疾病复发的风险更高。
World J Urol. 2018 Feb;36(2):177-185. doi: 10.1007/s00345-017-2122-5. Epub 2017 Nov 21.
5
Tumor Characteristics and Oncologic Outcome after Radical Prostatectomy in Men 75 Years Old or Older.75 岁及以上男性行根治性前列腺切除术的肿瘤特征和肿瘤学结局。
J Urol. 2016 Jul;196(1):89-94. doi: 10.1016/j.juro.2016.01.009. Epub 2016 Jan 18.
6
Impact of a family history of prostate cancer on clinicopathologic outcomes and survival following radical prostatectomy.前列腺癌家族史对根治性前列腺切除术后临床病理结果及生存的影响。
World J Urol. 2016 Aug;34(8):1115-22. doi: 10.1007/s00345-015-1738-6. Epub 2015 Dec 9.
7
Screening for familial and hereditary prostate cancer.家族性和遗传性前列腺癌的筛查。
Int J Cancer. 2016 Jun 1;138(11):2579-91. doi: 10.1002/ijc.29949. Epub 2016 Feb 5.
8
No Detrimental Effect of a Positive Family History on Long-Term Outcomes Following Radical Prostatectomy.家族史阳性对前列腺癌根治术后长期预后无不良影响。
J Urol. 2016 Feb;195(2):343-8. doi: 10.1016/j.juro.2015.07.097. Epub 2015 Jul 31.
9
A Family History of Lethal Prostate Cancer and Risk of Aggressive Prostate Cancer in Patients Undergoing Radical Prostatectomy.接受根治性前列腺切除术患者的致命性前列腺癌家族史与侵袭性前列腺癌风险
Sci Rep. 2015 Jun 26;5:10544. doi: 10.1038/srep10544.
10
Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.英国男性中 HOXB13 G84E 种系突变的流行率及其与前列腺癌风险、肿瘤特征和临床结局的相关性。
Ann Oncol. 2015 Apr;26(4):756-761. doi: 10.1093/annonc/mdv004. Epub 2015 Jan 16.